Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, iSpecimen Inc. reported revenue of $2M, down 79.2% year over year. Operating margin was -465.4% and net margin -543.7%, on a free-cash-flow margin of -219.9% with capital expenditure at 0.0% of revenue. Every figure is computed directly from ISPC's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2M | -465.4% | -543.7% |
| FY2024 | $9M | -137.0% | -134.5% |
| FY2023 | $10M | -112.5% | -111.8% |
| FY2022 | $10M | -97.9% | -98.5% |
| FY2021 | $11M | -53.2% | -80.5% |
How does ISPC compare against its actual peer set?
The full CompsDesk Peer Benchmark Pack: up to 14 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, provenance for every number, board-ready PDF + CSV. One-off $249.
Related in the same sector: AACG · ABSI · ACCS · ACM · ADUS · AGL
See ISPC benchmarked against two sector peers (free) →
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.